Pulse Biosciences, Inc.
PLSE· Nasdaq
PLSEPulse Biosciences, Inc.
Filed Nov 9, 2020 · 10-Q · 40 days after period end · 0001625101-20-000050
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$12.90M | -$11.75M | -$10.76M | -$7.49M |
| EPS Diluted | -$0.51 | -$0.57 | -$0.64 | -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 9, 2020 · 40 d after period end
